Navigation Links
The Medical Affairs Company Expands Its Medical Communications Division
Date:2/23/2009

ATLANTA, Feb. 23 /PRNewswire/ -- The Medical Affairs Company LLC (TMAC(R)), the leading provider of outsourced medical science liaison (MSL) services, announced today a significant expansion of its medical communications division.

In response to an increasing client demand for clinician-staffed, project-based medical information and medical meeting surveillance services, TMAC has recently expanded the size of its Medical Communications division to better meet these needs. This expansion strengthens TMAC's ability to provide the pharmaceutical, biotechnology and medical device industries with a complete array of outsourcing capabilities for medical affairs activities.

    TMAC's Medical Communications capabilities include the provision of:

    -- Inbound and Outbound Medical Information Services
    -- Adverse Event (AE) and Product Complaint (PC) handling
    -- Medical Writing including standard letter, FAQ, SOP development
    -- Literature Surveillance and Summarization, including Pharmacovigilance
    -- Medical Meeting Surveillance and Support

"Expanding our core medical affairs offering to include clinician-staffed, highly customized Medical Communications services considerably enhances our Contract Medical Organization (CMO) model," states Dr. Evan Demestihas, TMAC's CEO. He adds, "Importantly, this expansion provides our clients with strategic, flexible and cost-efficient options. In today's economic environment, clients want to be assured that they are spending their budgets wisely and using their resources efficiently. TMAC's flexible offerings allow clients to better utilize their internal resources to focus on their current priorities, while we focus on implementing their medical affairs strategies with expertly trained healthcare professionals."

About The Medical Affairs Company

The Medical Affairs Company LLC (TMAC(R)) is a full service Contract Medical Organization that provides pharmaceutical, biotechnology, and medical device industry clients a wide array of outsourcing capabilities for medical affairs activities. Providing both strategic and tactical medical science liaison support services in addition to medical science liaison consulting and medical communications support, TMAC is uniquely positioned to provide both unmatched value and service to the pharmaceutical industry. TMAC's greatest strength is their focus: medical and scientific affairs - it is their only business.

Please visit TMAC's website at: TheMedicalAffairsCompany.com.


'/>"/>
SOURCE The Medical Affairs Company LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Feb. 20, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) announced ... CEO and Fabrice Orecchioni, the company,s COO, has been named President, ... the past four years, Fabrice has overseen the construction, start-up and ... and the management of the Mitsui JV.  Fabrice has also been ... China JV. ...
(Date:2/20/2017)... ... 20, 2017 , ... Salford-based Mettler Toledo Safeline, which employs ... processing and packaging industries, was runner-up for the Environmental Achievement Award, sponsored by ... or taken the most innovative steps to improve its environmental performance. , ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... among radiotherapy patients, prevent chest wall collapses in pre-term infants with respiratory ... receive a total of $600,000 in funding through the ninth round of ...
(Date:2/20/2017)... , Feb. 20, 2017  At the ... in Orlando , IBM (NYSE: ... collaborators and clients. IBM Chairman, President and CEO ... opening keynote address today from 8:30-10 am ET, ... , and ibm.com/industries/healthcare. Her remarks examine the advent ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/8/2017)... 2017 Report Highlights The global ... $8.3 billion in 2016 at a compound annual growth ... Report Includes - An overview of the global market ... data from 2015 and 2016, and projections of compound ... the market on the basis of product type, source, ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):